Seebri

Made by

• Novartis

Active Ingredient

Glycopyrrolate

Prospectus

Approval date

2012/9/28

Treats

• Chronic obstructive pulmonary disease (COPD), Emphysema

Dosages

• seebri inhalation capsules 50μg - 175円／カプセル